Equitas Small Finance Bank Regulatory Approval

Equitas Small Finance Bank Other Announcement

The company submitted its quarterly shareholding pattern for the period ending September 30, 2026. This is a periodic regulatory compliance filing required under SEBI listing regulations.

Equitas Small Finance Bank Board Meeting Date

Equitas Small Finance Bank will hold a board meeting on 29 Oct 2026 to consider unaudited H1 FY27 standalone results. No financial figures are disclosed.

Equitas Small Finance Bank Credit Rating

Equitas Small Finance Bank announced that CARE Ratings reaffirmed the "CARE AA-; Stable" rating for its issuer, Lower Tier II, and Tier II bond issues.

Equitas Small Finance Bank Employee Stock Options

Equitas Small Finance Bank allotted 4,574 equity shares to employees upon the exercise of stock options under its 2019 ESOP scheme.

Equitas Small Finance Bank Other Announcement

Equitas Small Finance Bank notified exchanges about its social media communication regarding the SEBI-mandated special window for the re-lodgement of physical shares.

Equitas Small Finance Bank Business Update

Equitas Small Finance Bank reported provisional business updates for Q2 FY27, with gross advances reaching ₹50,694 Crore. Total deposits grew to ₹52,483 Crore for the period.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.